Vizora日本語

Pharma Foods InternationalPharma Foods International Co., Ltd.2929東証プライム食料品FY ending Jul 2025, consolidated, J-GAAP

Pharma Foods International revenue and profit

Out of every ¥100 of sales, about ¥4 is left as operating profit. Revenue changed +5.0% from the prior year, operating profit -53.7%.

Five-year trend

Revenue¥65.3B
FY ending Jul 2021: ¥46.8B¥46.8BFY ending Jul 2022: ¥60.2B¥60.2BFY ending Jul 2023: ¥68.6B¥68.6BFY ending Jul 2024: ¥62.1B¥62.1BFY ending Jul 2025: ¥65.3B¥65.3BFY21FY22FY23FY24FY25
Operating income¥2.37B
FY ending Jul 2021: ¥5.67B¥5.67BFY ending Jul 2022: ¥1.08B¥1.08BFY ending Jul 2023: ¥3.61B¥3.61BFY ending Jul 2024: ¥5.11B¥5.11BFY ending Jul 2025: ¥2.37B¥2.37BFY21FY22FY23FY24FY25
Operating margin3.6%
FY ending Jul 2021: 12.1%12.1%FY ending Jul 2022: 1.8%1.8%FY ending Jul 2023: 5.3%5.3%FY ending Jul 2024: 8.2%8.2%FY ending Jul 2025: 3.6%3.6%FY21FY22FY23FY24FY25

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin0.6%
Asset turnover1.89×
ROA1.1%
ROA1.1%
Financial leverage3.09×
ROE3.3%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin0.6%
2021: 8.2%8.2%2023: 4.5%4.5%2024: 5.2%5.2%2025: 0.6%0.6%2122232425
Asset turnover1.89×
2021: 2.23×2.23×2023: 2.04×2.04×2024: 1.71×1.71×2025: 1.89×1.89×2122232425
ROA1.1%
2021: 18.3%18.3%2022: -1.4%-1.4%2023: 9.1%9.1%2024: 8.8%8.8%2025: 1.1%1.1%2122232425
Financial leverage3.09×
2021: 2.48×2.48×2023: 4.13×4.13×2024: 3.58×3.58×2025: 3.09×3.09×2122232425
ROE3.3%
2021: 45.4%45.4%2023: 37.7%37.7%2024: 31.5%31.5%2025: 3.3%3.3%2122232425
PeriodNet marginAsset turnoverROAFinancial leverageROE
20218.2%2.23×18.3%2.48×45.4%
2022——×-1.4%—×—
20234.5%2.04×9.1%4.13×37.7%
20245.2%1.71×8.8%3.58×31.5%
20250.6%1.89×1.1%3.09×3.3%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue7.2%
2020: 11.5%11.5%2021: 3.9%3.9%2022: 7.4%7.4%2023: 6.4%6.4%2024: 7.4%7.4%2025: 7.2%7.2%202122232425
PPE ÷ total assets14.4%
2020: 17.5%17.5%2021: 8.6%8.6%2022: 14.3%14.3%2023: 12.2%12.2%2024: 12.6%12.6%2025: 14.4%14.4%202122232425
Goodwill ÷ parent equity0.6%
2020: 3.1%3.1%2021: 1.7%1.7%2022: 3.8%3.8%2023: 2.1%2.1%2024: 1.1%1.1%2025: 0.6%0.6%202122232425
Goodwill balance¥71M
2020: ¥153M¥153M2021: ¥140M¥140M2022: ¥270M¥270M2023: ¥197M¥197M2024: ¥124M¥124M2025: ¥71M¥71M202122232425

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥1.4B
2020: ¥437.7M¥437.7M2022: ¥766M¥766M2023: ¥840M¥840M2024: ¥978M¥978M2025: ¥1.4B¥1.4B202122232425
R&D / revenue2.1%
2020: 2.9%2.9%2022: 1.3%1.3%2023: 1.2%1.2%2024: 1.6%1.6%2025: 2.1%2.1%202122232425
Receivable days28d
2020: 53d53d2021: 38d38d2022: 41d41d2023: 22d22d2024: 24d24d2025: 28d28d202122232425
Payable days55d
2020: 52d52d2021: 44d44d2022: 36d36d2023: 26d26d2024: 34d34d2025: 55d55d202122232425

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Jul 2021FY ending Jul 2022FY ending Jul 2023FY ending Jul 2024FY ending Jul 2025
Revenue46,75260,18568,57262,14765,260
Cost of revenue7,02712,07713,29313,39512,676
Gross profit39,72448,10855,27948,75152,583
SG&A34,05147,02851,66943,63850,215
Operating income5,6731,0803,6105,1132,367
Pretax income5,7651,4233,5425,0342,434
Income tax1,9241,7974621,8282,066
Net income attributable to owners3,841-3743,0813,205368
Operating margin12.1%1.8%5.3%8.2%3.6%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 28%
Receivables 15%
Property, plant and equipment 14%
1%
8%
Other assets 34%

Funding

6%
Other liabilities 59%
Equity 35%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Jul 2021FY ending Jul 2022FY ending Jul 2023FY ending Jul 2024FY ending Jul 2025
Cash and equivalents¥9.79B¥8.85B¥16.3B¥15.6B¥9.06B
Total assets¥20.9B¥31.2B¥36.2B¥36.6B¥32.6B
Net assets¥8.46B¥7.07B¥9.63B¥11.6B¥11.5B
Share capital¥2.04B¥2.04B¥2.04B¥2.04B¥2.04B
Trade receivables¥4.92B¥6.7B¥4.06B¥4.04B¥5.04B
Property, plant and equipment¥1.81B¥4.46B¥4.4B¥4.61B¥4.7B
Intangible assets excluding goodwill¥185M¥305M¥238M¥177M¥120M
Goodwill¥140M¥270M¥197M¥124M¥71M
Investment securities¥335M¥1.57B¥2.51B¥3.04B¥2.45B
Current assets¥17.9B¥23.5B¥27.5B¥27.3B¥23.9B
Current liabilities¥11B¥22.8B¥24.4B¥23.2B¥20B
Trade payables¥846M¥1.18B¥937M¥1.25B¥1.92B
Short-term borrowings¥2.5B¥15.4B¥17.4B¥14.9B¥11.4B
Long-term borrowings¥1.46B¥697M¥1.74B¥1.23B¥671M
Total liabilities¥12.5B¥24.1B¥26.6B¥25B¥21.1B
Non-controlling interests—¥2M———
Equity attributable to owners of parent¥8.46B¥7.02B¥9.31B¥11B¥11.4B
Retained earnings¥4.6B¥3.3B¥5.79B¥8.36B¥7.69B
Treasury stock—-¥138M-¥343M-¥1.19B-¥195M

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第28期(2024/08/01－2025/07/31)

    ID S100WW382025-10-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第27期(2023/08/01－2024/07/31)

    ID S100UKTG2024-10-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第26期(2022/08/01－2023/07/31)

    ID S100S2IX2023-10-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第25期(令和3年8月1日－令和4年7月31日)

    ID S100PDNZ2022-10-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第24期(令和2年8月1日－令和3年7月31日)

    ID S100MMP32021-10-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第23期(令和1年8月1日－令和2年7月31日)

    ID S100JY6D2020-10-20Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image